rss
Postgrad Med J 85:614-621 doi:10.1136/pgmj.2008.078014
  • Review

The metabolic syndrome: common origins of a multifactorial disorder

Table 1

Features of the World Health Organization (WHO), European Group for the Study of Insulin Resistance (EGIR), National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP-III) and International Diabetes Federation (IDF) definitions of metabolic syndrome

WHO (WHO consultation, 1999). Impaired glucose tolerance or diabetes and/or insulin resistance and two other factors EGIR (Balkau and Charles, 199910). Presence of fasting hyperinsulinaemia (the highest 25%) and two other factors ATP-III (NCEP Expert Panel on Detection, 2001). Three or more of the following factors (TAGs and HDL counted separately) IDF. Central obesity and two other factors (www.idf.org)
Central obesity WHR ⩾0.9 (men), 0.85 (women) and/or BMI >30 kg/m2 Waist ⩾94 cm (men), ⩾80 cm (women) Waist ⩾102 cm (men), >88 cm (women) Waist >94 cm (European men), >90 cm (Asian men), >80 cm (women)
Blood pressure (mm Hg) ⩾140/90 ⩾140/90 or treated for hypertension >130/85 or treated for hypertension ⩾130 SBP or ⩾85 DBP or treated for hypertension
Dyslipidaemia (mmol/l) TAGs ⩾1.7, HDL <0.9 (men), <1.0 (women) TAGs ⩾2.0 or HDL-cholesterol <1.0 or treated for dyslipidaemia TAGs ⩾1.7, HDL-cholesterol: <1.0 (men), <1.3 (women) TAGs ⩾1.7, HDL-cholesterol, <1.04 (men), <1.29 (women)
Dysglycaemia (mmol/l) Fasting glucose ⩾6.1 and/or 2 h post-challenge glucose ⩾7.8 on diabetes Fasting plasma glucose >6.1, but non-diabetic Fasting plasma glucose ⩾6.1 Fasting glucose ⩾5.6 or previous diagnosis of impaired glucose tolerance or diabetes
Insulin resistance Glucose uptake during hyperinsulinaemic–euglycaemic clamp in lowest quartile for population Presence of fasting hyperinsulinaemia (ie, among the highest 25% of the non-diabetic population) Not applicable Not applicable
Other factors WHO (WHO consultation, 1999). Impaired glucose tolerance or diabetes and/or insulin resistance and two other factors) EGIR (Balkau and Charles, 199910). Presence of fasting hyperinsulinaemia (the highest 25%) and two other factors Microalbuminuria (urinary albumin excretion rate >20 μg/min or albumin/creatinine ratio >30 mg/g) None
  • BMI, body mass index; DBP, diastolic blood pressure; HDL, high-density lipoprotein; SBP, systolic blood pressure; TAG, triacylglycerol; WHR, waist/hip ratio.

This Article


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of PMJ.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.